48 related articles for article (PubMed ID: 38728457)
1. Single-cell and bulk RNA sequencing reveal heterogeneity and diagnostic markers in papillary thyroid carcinoma lymph-node metastasis.
Lu DN; Zhang WC; Lin YZ; Jiang HY; He R; Li SL; Zhang YN; Shao CY; Zheng CM; Xu JJ; Ge MH
J Endocrinol Invest; 2024 Jun; 47(6):1513-1530. PubMed ID: 38146045
[TBL] [Abstract][Full Text] [Related]
2. Anoikis-related gene signatures in colorectal cancer: implications for cell differentiation, immune infiltration, and prognostic prediction.
Ding T; Shang Z; Zhao H; Song R; Xiong J; He C; Liu D; Yi B
Sci Rep; 2024 May; 14(1):11525. PubMed ID: 38773226
[TBL] [Abstract][Full Text] [Related]
3. Prognostic prediction of patients having classical papillary thyroid carcinoma with a 4 mRNA-based risk model.
Xiang L; Zhao JH; Tang Y; Tan JW; Li LB; Gong C
Medicine (Baltimore); 2024 Jun; 103(23):e38472. PubMed ID: 38847736
[TBL] [Abstract][Full Text] [Related]
4. Interactions between LAMP3+ dendritic cells and T-cell subpopulations promote immune evasion in papillary thyroid carcinoma.
Wang Z; Ji X; Zhang Y; Yang F; Su H; Zhang H; Li Z; Zhang W; Sun W
J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38816233
[TBL] [Abstract][Full Text] [Related]
5. System analysis based on Anoikis-related genes identifies MAPK1 as a novel therapy target for osteosarcoma with neoadjuvant chemotherapy.
Wu Z; Yu J; Han T; Tu Y; Su F; Li S; Huang Y
BMC Musculoskelet Disord; 2024 Jun; 25(1):437. PubMed ID: 38835052
[TBL] [Abstract][Full Text] [Related]
6. Identification and validation of a prognostic anoikis-related gene signature in papillary thyroid carcinoma by integrated analysis of single-cell and bulk RNA-sequencing.
Zheng K; Zhang XX; Yu X; Yu B; Yang YF
Medicine (Baltimore); 2024 May; 103(19):e38144. PubMed ID: 38728457
[TBL] [Abstract][Full Text] [Related]
7. Predicting the immune microenvironment and prognosis with a anoikis - related signature in breast cancer.
Lu X; Yuan Q; Zhang C; Wang S; Wei W
Front Oncol; 2023; 13():1149193. PubMed ID: 37469408
[TBL] [Abstract][Full Text] [Related]
8. Identification and validation of anoikis-associated gene SNCG as a prognostic biomarker in gastric cancer.
Li Y; Pan Q; Cheng M; Wu Z
Aging (Albany NY); 2023 Mar; 15(7):2541-2553. PubMed ID: 36996495
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatics based exploration of hsa-miR-194-5p regulation of CHD4 through PI3K/AKT signal pathway to enhance tumor resistance to apoptosis due to loss of nests and participate in poor prognosis of oral squamous cell carcinoma.
Li Q; Wang K; Shen Y; Lin C; Miao J; Hu X
Ann Transl Med; 2023 Jan; 11(2):107. PubMed ID: 36819582
[TBL] [Abstract][Full Text] [Related]
10. Estrogen-related genes influence immune cell infiltration and immunotherapy response in Hepatocellular Carcinoma.
Gao B; Wang Y; Li C; Lu S
Front Immunol; 2023; 14():1114717. PubMed ID: 36814910
[TBL] [Abstract][Full Text] [Related]
11. A novel Anoikis and immune-related genes marked prognostic signature for colorectal cancer.
Cai Z; Zhou F
Medicine (Baltimore); 2022 Nov; 101(46):e31127. PubMed ID: 36401385
[TBL] [Abstract][Full Text] [Related]
12. Optical diagnostic imaging and therapy for thyroid cancer.
Shao C; Li Z; Zhang C; Zhang W; He R; Xu J; Cai Y
Mater Today Bio; 2022 Dec; 17():100441. PubMed ID: 36388462
[TBL] [Abstract][Full Text] [Related]
13. In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer.
Dubrot J; Du PP; Lane-Reticker SK; Kessler EA; Muscato AJ; Mehta A; Freeman SS; Allen PM; Olander KE; Ockerman KM; Wolfe CH; Wiesmann F; Knudsen NH; Tsao HW; Iracheta-Vellve A; Schneider EM; Rivera-Rosario AN; Kohnle IC; Pope HW; Ayer A; Mishra G; Zimmer MD; Kim SY; Mahapatra A; Ebrahimi-Nik H; Frederick DT; Boland GM; Haining WN; Root DE; Doench JG; Hacohen N; Yates KB; Manguso RT
Nat Immunol; 2022 Oct; 23(10):1495-1506. PubMed ID: 36151395
[TBL] [Abstract][Full Text] [Related]
14. A Stk4-Foxp3-NF-κB p65 transcriptional complex promotes T
Cui Y; Benamar M; Schmitz-Abe K; Poondi-Krishnan V; Chen Q; Jugder BE; Fatou B; Fong J; Zhong Y; Mehta S; Buyanbat A; Eklioglu BS; Karabiber E; Baris S; Kiykim A; Keles S; Stephen-Victor E; Angelini C; Charbonnier LM; Chatila TA
Sci Immunol; 2022 Sep; 7(75):eabl8357. PubMed ID: 36149942
[TBL] [Abstract][Full Text] [Related]
15. Genetic characteristics involving the PD-1/PD-L1/L2 and CD73/A2aR axes and the immunosuppressive microenvironment in DLBCL.
Zhang T; Liu H; Jiao L; Zhang Z; He J; Li L; Qiu L; Qian Z; Zhou S; Gong W; Meng B; Ren X; Zhang H; Wang X
J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35365585
[TBL] [Abstract][Full Text] [Related]
16. An SCD1-dependent mechanoresponsive pathway promotes HCC invasion and metastasis through lipid metabolic reprogramming.
Liu HH; Xu Y; Li CJ; Hsu SJ; Lin XH; Zhang R; Chen J; Chen J; Gao DM; Cui JF; Yang XR; Ren ZG; Chen RX
Mol Ther; 2022 Jul; 30(7):2554-2567. PubMed ID: 35358687
[TBL] [Abstract][Full Text] [Related]
17. The effect and mechanism of miR-30e-5p targeting SNAI1 to regulate epithelial-mesenchymal transition on pancreatic cancer.
Liang Z; Tang S; He R; Luo W; Qin S; Jiang H
Bioengineered; 2022 Apr; 13(4):8013-8028. PubMed ID: 35300562
[TBL] [Abstract][Full Text] [Related]
18. DNA Repair and Replication-Related Gene Signature Based on Tumor Mutation Burden Reveals Prognostic and Immunotherapy Response in Gastric Cancer.
Zhang L; Hu D; Huangfu S; Zhou J; Wang W; Liu S; Tang H; Pan J; Pan Y
J Oncol; 2022; 2022():6469523. PubMed ID: 35058980
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
